
How Affordability Support Fits Into a Modern Patient Support Program
For brand, patient services, and market access leaders, affordability support is no longer a niche add-on. Public data indicate that more than 9 million U.S. adults ages 18 to 64

For brand, patient services, and market access leaders, affordability support is no longer a niche add-on. Public data indicate that more than 9 million U.S. adults ages 18 to 64

In pharma hub services, “user experience” is often understood as the patient’s experience with a call, portal, text message, or nurse navigator. That matters, but it is only half the

Co-pay assistance navigation is not just a financial add-on inside a patient support program. It is an operational function that helps patients move from prescription to first fill by identifying

Therapy abandonment in specialty pharma is often treated like an adherence problem. In practice, a meaningful share of abandonment starts earlier, before the patient ever begins therapy. Coverage checks, prior

A prescription may start the journey, but what happens next determines whether treatment leads to real progress. Patients leave with instructions, medications, and expectations, yet many still face barriers that

A prescription alone doesn’t guarantee progress. Patients may leave a visit with the right therapy in hand, yet still face challenges that affect whether they follow through. Missed doses, confusion

For many patients, starting a new treatment is only part of the journey. Staying on that therapy can be just as difficult. High health care costs, gaps in insurance coverage,

A Patient Relationship Management platform, often shortened to PRM, is the operational system that organizes patient support program work from first contact through ongoing engagement. In practice, PRM platforms unify

Why device support and concierge services are suddenly a board-level topic Commercial patient support programs used to be defined mainly by reimbursement workflows. That is still true, but the center

The commercialization of specialty medications has transformed the pharmaceutical industry. Many of today’s therapies—particularly those used to treat rare diseases, cancer, or complex chronic conditions—require extensive coordination between healthcare providers,